Literature DB >> 4302515

Cander risk in intraductal papilloma and papillomatosis.

S E Buhl-Jorgensen, K Fischermann, H Johansen, B Petersen.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 4302515

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


× No keyword cloud information.
  9 in total

1.  Computerized Image Analysis of Clustered Microcalcifications on Mammography: Morphome- tric Comparison between Mammography and Pathology.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  [Mammary cancer risk subsequent to papillary proliferations (author's transl)].

Authors:  M Bergholz; A Schauer; H Reck; A Gregl
Journal:  Langenbecks Arch Chir       Date:  1979-06-26

3.  The operative management of intraductal papilloma of the breast.

Authors:  R Abe
Journal:  Jpn J Surg       Date:  1990-03

4.  Characteristics of nipple discharge lesions of the breast and contrast mammography.

Authors:  T Amaaki; K Enomoto; A Kosaka; L J Faulkin
Journal:  Jpn J Surg       Date:  1974-06

Review 5.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Selective ductectomy for the diagnosis and treatment of intraductal papillary lesions presenting with single duct discharge.

Authors:  R Maráz; G Boross; E Ambrózay; M Svébis; G Cserni
Journal:  Pathol Oncol Res       Date:  2013-03-24       Impact factor: 3.201

7.  The diagnostic value of testing for occult blood.

Authors:  M A Chaudary; R R Millis; G C Davies; J L Hayward
Journal:  Ann Surg       Date:  1982-12       Impact factor: 12.969

8.  Twenty-year outcome following central duct resection for bloody nipple discharge.

Authors:  R Scott Nelson; James L Hoehn
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

9.  Male breast cancer. 5. Clinical manifestations in 257 cases in Denmark.

Authors:  O Scheike
Journal:  Br J Cancer       Date:  1973-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.